Published: Apr 12, 2026
Written by Klarity Editorial Team
Published: Apr 12, 2026

If you’re struggling with binge eating disorder (BED), you might be wondering whether telehealth could be your path to treatment. The short answer is yes—and it’s more accessible than ever in 2026. With evolving regulations and expanded telehealth services, getting professional help and prescription medication for BED without leaving your home is now a reality for most Americans.
This comprehensive guide will walk you through everything you need to know about accessing BED treatment via telehealth, including which medications can be prescribed online, state-by-state regulations, and what to expect from your virtual care experience.
Binge eating disorder is the most common eating disorder in the United States, affecting millions of people across all demographics. It’s characterized by recurrent episodes of eating large amounts of food in a discrete period (typically within two hours), accompanied by a sense of loss of control and significant distress—without the compensatory purging behaviors seen in bulimia.
Yes, absolutely. For non-controlled medications commonly used to treat BED—such as Topamax (topiramate) and Wellbutrin (bupropion)—telehealth providers can legally prescribe them in every U.S. state, as long as they’re licensed in your state and follow standard medical care protocols.
Here’s why: These medications are not controlled substances under the DEA’s scheduling system. The strict federal in-person examination requirements (under the Ryan Haight Act) only apply to controlled medications like stimulants or opioids—not to the non-controlled medications typically used for BED treatment.
The Ryan Haight Act of 2008 established rules requiring an in-person medical evaluation before prescribing controlled substances via telemedicine. However, this law does not apply to non-controlled medications like topiramate or bupropion.
This means that at the federal level, there are no special restrictions on prescribing these BED medications through telehealth—they can be prescribed just as they would be in a traditional office setting, as long as the provider meets standard care requirements.
While the Ryan Haight Act doesn’t affect non-controlled BED medications, it’s worth noting that the DEA has extended COVID-era flexibilities for controlled substance prescribing through December 31, 2026. This extension demonstrates the federal government’s continued commitment to telehealth access while permanent regulations are finalized.
For patients seeking BED treatment with non-controlled medications, this means your telehealth access remains completely open and stable through 2026 and beyond.
While federal law sets the baseline, individual states have their own telehealth regulations. The good news? Most states have made permanent the pandemic-era flexibilities that allow telehealth exams to substitute for in-person visits when prescribing non-controlled medications.
The majority of states—including California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina—have no mandatory in-person visit requirement for prescribing non-controlled medications like those used for BED.
In these states, a thorough telehealth evaluation (typically via video consultation) is considered equivalent to an in-person exam for prescribing purposes. California has even explicitly stated that an appropriate evaluation can be conducted via video or asynchronous (online questionnaire) methods if it meets the standard of care.
A small number of states require periodic in-person visits for ongoing telehealth treatment:
Alabama: If you receive more than four telehealth visits in 12 months for the same condition, an in-person visit must occur within that year. However, this can often be satisfied by seeing any collaborating provider in person—not necessarily your telehealth prescriber.
Georgia: Requires at least an attempt at an annual in-person examination for continued telemedicine care, though initial evaluation can be done via telehealth if it’s equivalent to an in-person exam.
New Hampshire: For controlled medications (not typically relevant for BED), requires an in-person follow-up at least every 12 months. Non-controlled medications have no such requirement.
Even in these states, you can start treatment entirely online—the periodic in-person requirements only apply to long-term continuation of care.
Not all telehealth BED prescriptions come from physicians. Nurse practitioners (NPs) and physician assistants (PAs) can also prescribe these medications, though their level of independence varies by state.
Independent Practice States: In approximately 34 states (plus Washington, D.C.), NPs have full practice authority, meaning they can evaluate patients and prescribe medications independently without physician oversight. Recent additions include:
Collaborative Practice States: In states like Texas, Florida, Georgia, and Alabama, NPs and PAs must work under a collaborative agreement or supervision arrangement with a physician. This doesn’t typically affect your care experience—it’s a behind-the-scenes regulatory requirement—though you might see both the NP’s and supervising physician’s names on documentation.
For non-controlled medications like those used in BED treatment, collaborative requirements are minimal, and any licensed prescriber (MD, DO, NP, or PA) working with a legitimate telehealth service can provide your medication.
Classification: Non-controlled prescription medication (legend drug)
FDA Approval: Seizures and migraine prevention (BED use is off-label)
Telehealth Status: ✅ Fully available via telehealth nationwide
Topiramate is frequently prescribed off-label for BED due to its effects on impulse control and appetite regulation. Clinical research has shown it can help reduce binge frequency and support weight management in some patients.
What to Know:
Classification: Non-controlled prescription medication
FDA Approval: Depression and smoking cessation (BED use is off-label)
Telehealth Status: ✅ Fully available via telehealth nationwide
Bupropion has shown promise in reducing binge eating episodes in clinical studies and is commonly prescribed for BED, especially when depression or mood symptoms coexist.
What to Know:
You might notice that neither topiramate nor bupropion is FDA-approved specifically for BED. The only FDA-approved medication for BED is actually Vyvanse (lisdexamfetamine), a controlled stimulant.
However, off-label prescribing is completely legal, common, and often represents the standard of care for many conditions, including BED. Clinical research supports the use of both topiramate and bupropion for reducing binge eating episodes, and providers who prescribe them are following evidence-based practice guidelines.
A reputable telehealth provider will explain why they’re recommending a particular medication, discuss the evidence supporting its use, and obtain your informed consent for off-label treatment.
When you schedule a telehealth visit for BED treatment, expect a comprehensive evaluation similar to what you’d receive in person. This typically includes:
Clinical Interview (usually 30-45 minutes):
Diagnostic Criteria Assessment: Your provider will determine if you meet DSM-5 criteria for BED, which include:
Identity and Location Verification: Don’t be surprised when your provider verifies your identity and confirms your physical location. This is required in many states and ensures the provider is licensed where you’re receiving care—it’s a protective measure, not an invasion of privacy.
Before prescribing medication, your telehealth provider will screen for conditions that might make certain treatments unsafe:
You may not be a candidate for telehealth BED medication if you have:
Lab Work and Testing: Your provider may request recent lab results (metabolic panel, thyroid function, liver enzymes) or recommend getting labs done before starting medication. While this can often be arranged at a local lab, some complex situations may require an in-person medical evaluation.
Many states maintain Prescription Drug Monitoring Programs that track controlled substance prescriptions. Since topiramate and bupropion are not controlled substances, most states don’t mandate PMP checks before prescribing them.
However, your telehealth provider may still review your medication history as a safety precaution—for example, to ensure you’re not already taking another formulation of bupropion or to check for potential drug interactions. This is considered best practice rather than a legal requirement for these medications.
Starting medication for BED through telehealth follows the same best practices as in-person care:
Start Low, Go Slow: Providers typically begin with the lowest effective dose and gradually increase based on your response and tolerance. This ‘titration’ approach minimizes side effects.
Combination with Therapy: Reputable telehealth providers recognize that medication is just one component of BED treatment. Expect discussion of:
At Klarity Health, our providers take a comprehensive approach to BED treatment, offering not just medication management but also connecting you with therapy resources and ongoing support—all with transparent pricing and the flexibility to use insurance or pay cash.
Typical telehealth follow-up timeline:
Some states require periodic follow-up within specific timeframes. Your provider will ensure you’re scheduled appropriately based on both clinical needs and regulatory requirements.
Because these medications aren’t controlled substances, providers can often authorize refills for extended periods (up to 6-12 months depending on state regulations). However, you’ll still need regular follow-up appointments to:
Prescriptions are sent electronically to your chosen pharmacy—you should never receive medication directly from a telehealth company for these prescription drugs. Legitimate services use licensed pharmacies, ensuring you receive FDA-approved medications with proper labeling and instructions.
The telehealth boom has brought both tremendous benefits and some concerning practices. Here’s how to distinguish quality care from problematic services:
Warning signs of low-quality telehealth:
Signs of quality telehealth care:
The federal government has cracked down on some problematic telehealth practices. For example, executives of a California-based ADHD telehealth startup were indicted in 2024 for prescribing massive quantities of Adderall with inadequate evaluations, contributing to drug shortages and potentially endangering patients.
These enforcement actions target bad actors while preserving access to legitimate telehealth services. They’ve led to improved industry standards, with reputable platforms implementing:
At Klarity Health, we’ve built our telehealth platform around the principle that convenient care should never compromise quality. Our approach includes:
We believe that people struggling with BED deserve access to expert care without the barriers of long wait times, geographic limitations, or confusing costs.
Most insurance plans now cover telehealth mental health services at parity with in-person visits, thanks to regulations implemented during the COVID-19 pandemic and subsequently extended.
Coverage typically includes:
What to verify with your insurance:
If you don’t have insurance or prefer not to use it, many telehealth platforms offer transparent self-pay pricing. Klarity Health, for example, provides upfront pricing for consultations and follow-up visits, allowing you to budget for care without surprise bills.
Typical costs (self-pay):
| Factor | Telehealth Treatment | Traditional In-Person |
|---|---|---|
| Appointment Availability | Often within days; flexible scheduling including evenings/weekends | May require weeks or months for specialist appointments |
| Geographic Access | Available regardless of location (as long as provider licensed in your state) | Limited by proximity to specialists; rural areas particularly underserved |
| Cost | Often lower due to reduced overhead; transparent pricing common | Variable; may include facility fees; pricing less transparent |
| Convenience | No travel time; attend from home | Requires travel; time away from work/family |
| Privacy | More discreet; no waiting room | Potential privacy concerns in waiting areas |
| Initial Assessment | Comprehensive virtual evaluation | Traditional physical exam possible if needed |
| Ongoing Monitoring | Regular video check-ins; messaging between visits often available | Scheduled in-person appointments |
| Medication Access | Full access to non-controlled medications; prescriptions sent to your pharmacy | Full access to all medications |
| Emergency Situations | Limited ability to handle acute medical emergencies | Immediate access to emergency protocols |
| Physical Exam | Not possible (may require in-person referral if needed) | Complete physical examination available |
| Best For | Most BED patients seeking medication management and therapy | Complex medical situations; patients preferring traditional care |
Possibly, but it depends on your individual situation. If you meet diagnostic criteria for BED, don’t have contraindications, and the provider determines medication is appropriate, a prescription can be written at the initial visit. However, some providers prefer to gather more information or coordinate with your other healthcare providers before prescribing.
The only FDA-approved medication specifically for BED is Vyvanse (lisdexamfetamine), a controlled stimulant. Due to stricter DEA regulations, most telehealth platforms do not prescribe controlled stimulants for BED. If your provider determines you might benefit from a controlled medication, they’ll likely refer you for an in-person evaluation.
For continuity of care, it’s generally best to see the same provider. However, telehealth platforms typically have systems in place for another provider to cover if yours is unavailable. All your visit notes and treatment history are maintained in your electronic health record for seamless care.
Provider licensing is state-specific. If you move, you’ll need to find a provider licensed in your new state. Some larger telehealth platforms have providers in multiple states and can facilitate transfers. Be sure to inform your provider if you’re planning to relocate.
Absolutely! Coordinated care is ideal. With your written consent, your telehealth provider can communicate with your therapist, primary care doctor, or other healthcare providers to ensure everyone is on the same page about your treatment plan.
This is exactly why regular follow-up is essential. If you experience problematic side effects or don’t see improvement, contact your provider. Medications can be adjusted, switched, or discontinued as needed. Never stop medication abruptly without consulting your provider, especially topiramate (which requires tapering to prevent seizures).
Yes. Telehealth platforms must comply with HIPAA (Health Insurance Portability and Accountability Act) regulations, ensuring your medical information is protected. Video platforms use encryption and secure connections. Your provider cannot share your information without your written consent (except in specific safety situations like imminent harm).
Check that:
Before your appointment:
The most successful treatment outcomes happen when patients are engaged partners in their care:
Telehealth is excellent for many aspects of BED treatment, but some situations require in-person evaluation:
Your telehealth provider will recognize these situations and coordinate appropriate referrals.
As we move through 2026, telehealth has become a permanent, integral part of mental healthcare delivery. The regulatory framework continues to evolve, generally in directions that:
For people with BED, this means greater access to specialized care, shorter wait times, and more options for comprehensive treatment—all from the privacy and convenience of home.
If you’re struggling with binge eating disorder, you don’t have to face it alone—and you don’t have to wait weeks or months for an appointment. Telehealth has made expert, compassionate care accessible to more people than ever before.
Ready to get started? Klarity Health offers:
Getting help for BED is a sign of strength, not weakness. With the accessibility and privacy of telehealth, there’s never been a better time to take that important first step toward recovery.
Verified as of: January 4, 2026
⚠️ Monitor: Alabama and South Carolina NP scope changes (legislation discussed in 2025 but final status pending confirmation—assume no full independence yet). DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
U.S. Department of Health and Human Services. (January 2, 2026). ‘HHS Announces DEA Extension of Telemedicine Prescribing Flexibilities Through December 31, 2026.’ HHS.gov. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. (August 2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (November-December 2025). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ CCHP State Telehealth Policy Database. https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. (2025). ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
The National Law Review. (2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Find the right provider for your needs — select your state to find expert care near you.